The Doctor Youn Show cover image

Microdosing, Big Pharma, and Weight Loss: Inside GLP-1 Agonists Ozempic, Wegovy, Zepbound and Others with Dr. Tyna Moore

The Doctor Youn Show

CHAPTER

Exploring Compounded vs. Brand Name Medications for Metabolic Health

This chapter explores the distinctions between compounded somacthotide and brand-name terzepatide, highlighting cost, accessibility, and metabolic benefits. It also addresses the insurance coverage challenges patients encounter and shares personal experiences of navigating these hurdles.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner